Immunogen Design to enhance the efficacy of Plasmodium vivax vaccine
增强间日疟原虫疫苗功效的免疫原设计
基本信息
- 批准号:7881375
- 负责人:
- 金额:$ 24.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAfricaAntibodiesAntibody FormationAntigen ReceptorsAntigensBindingBinding ProteinsBinding SitesBiological AssayBlocking AntibodiesCarrier ProteinsClinicalConjugate VaccinesCouplingCover-upCysteineDevelopmentDiseaseDrug FormulationsEconomicsElectron MicroscopyEnhancing AntibodiesEnzyme-Linked Immunosorbent AssayEpitopesGelGoalsHaplotypesHumanImmunizationIn VitroLatin AmericaLife Cycle StagesLinkLocationLysineMalariaMolecular WeightMorbidity - disease rateMusOryctolagus cuniculusParasitesPlasmodium falciparumPlasmodium vivaxPlasmodium vivax vaccinePreparationProteinsRecombinant ProteinsReticulocytesRunningSerumSiteSoutheastern AsiaStructureSucroseTestingVaccinesVirus-like particlechemokinedesignimmunogenicimmunogenicitymonomernovelparasite invasionparticlepreventpublic health relevanceresearch studyvaccine developmentvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): Plasmodium vivax is a major cause of clinical malaria outside of Africa and causes substantial morbidity and economic loss in the developing world. P. vivax presents unique opportunities for invasion blocking vaccine approaches because the parasite is highly selective for reticulocytes and depends on the human DARC protein for invasion. This selectivity differentiates P. vivax from P. falciparum, and provides considerable advantages for development of invasion blocking vaccines. P. vivax binds to DARC via the region II in the P. vivax Duffy binding protein (PvDBPII). Antibodies to PvDBPII inhibit parasite invasion, but the main obstacle to vaccine development is generating high titer functional antibodies that will prevent disease. In this project, we will determine if PvDBPII immunogenicity can be enhanced by conjugating to HepB core antigen particles and investigate whether the antibody response can be further focused by orienting the recombinant protein with the predicted DARC interaction site exposed and covering up off-target polymorphic epitopes.
PUBLIC HEALTH RELEVANCE: Plasmodium vivax is a major cause of clinical malaria in many parts of Southeast Asia and Latin America and causes substantial morbidity and economic loss in the developing world. The goal of this project is to use rational immunogen design to enhance the efficacy of a P. vivax vaccine by conjugating PvDBPII recombinant protein on virus-like particles (VLP) and orienting the protein so as to maximize antibody reactivity to the predicted DARC interaction site.
描述(由申请人提供):间日疟原虫是非洲以外临床疟疾的主要原因,在发展中国家造成大量发病率和经济损失。间日疟原虫为入侵阻断疫苗方法提供了独特的机会,因为这种寄生虫对网织红细胞具有高度的选择性,并依赖于人类DARC蛋白进行入侵。这种选择性区分了间日疟原虫和恶性疟原虫,为开发入侵阻断疫苗提供了相当大的优势。间日疟原虫通过间日疟原虫Duffy结合蛋白(PvDBPII)中的II区与DARC结合。PvDBPII抗体可以抑制寄生虫的入侵,但疫苗开发的主要障碍是产生能够预防疾病的高滴度功能性抗体。在这个项目中,我们将确定PvDBPII是否可以通过与乙肝核心抗原颗粒结合来增强免疫原性,并研究是否可以通过将重组蛋白与预测的DARC相互作用位点定位并掩盖靶标外的多态表位来进一步聚焦抗体反应。
公共卫生相关性:间日疟原虫是东南亚和拉丁美洲许多地区临床疟疾的主要原因,并在发展中国家造成大量发病率和经济损失。本项目的目标是利用合理的免疫原设计,通过将PvDBPII重组蛋白连接到病毒样颗粒(VLP)上并对其进行定向,以最大限度地提高抗体对预测的DARC相互作用位点的反应性,从而提高间日疟原虫疫苗的效力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH D SMITH其他文献
JOSEPH D SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH D SMITH', 18)}}的其他基金
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10466868 - 财政年份:2020
- 资助金额:
$ 24.61万 - 项目类别:
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10116030 - 财政年份:2020
- 资助金额:
$ 24.61万 - 项目类别:
Mechanisms of endothelial dysfunction in cerebral malaria and barrier restorative pathways
脑型疟疾内皮功能障碍机制及屏障恢复途径
- 批准号:
10269051 - 财政年份:2020
- 资助金额:
$ 24.61万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
10454338 - 财政年份:2019
- 资助金额:
$ 24.61万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
10216994 - 财政年份:2019
- 资助金额:
$ 24.61万 - 项目类别:
Molecular Mechanisms in Pediatric Cerebral Malaria Pathogenesis and Immunity
小儿脑型疟疾发病机制和免疫的分子机制
- 批准号:
9817075 - 财政年份:2019
- 资助金额:
$ 24.61万 - 项目类别:
3D human-based microvessel bed for the study of Plasmodium falciparum interacting with vessel wall
用于研究恶性疟原虫与血管壁相互作用的 3D 人体微血管床
- 批准号:
9015016 - 财政年份:2015
- 资助金额:
$ 24.61万 - 项目类别:
Binding Mechanisms in P.falciparum Cerebral Malaria
恶性疟原虫脑型疟疾的结合机制
- 批准号:
8712760 - 财政年份:2013
- 资助金额:
$ 24.61万 - 项目类别:
Immunogen Design to enhance the efficacy of Plasmodium vivax vaccine
增强间日疟原虫疫苗功效的免疫原设计
- 批准号:
8050581 - 财政年份:2010
- 资助金额:
$ 24.61万 - 项目类别:
相似海外基金
Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
- 批准号:
10106976 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
- 批准号:
EP/Y024516/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
- 批准号:
24K00390 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
- 批准号:
MR/X022943/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Fellowship
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
- 批准号:
MR/Y003837/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
- 批准号:
MR/Y019695/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Research Grant
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
- 批准号:
10076185 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Collaborative R&D
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
- 批准号:
MR/Y00955X/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
- 批准号:
MR/Y015614/1 - 财政年份:2024
- 资助金额:
$ 24.61万 - 项目类别:
Research Grant